Actionable news
All posts from Actionable news
Actionable news in LCI: LANNETT COMPANY Inc,

Lannett Co: Robert Jaffe Co., Llc

The following excerpt is from the company's SEC filing.

(424) 288-4098


Philadelphia, PA

April 11, 2016

Lannett Company, Inc. (NYSE: LCI) today announced that its president, Michael J. Bogda, is leaving the company, effective June 3, 2016, to pursue other interests.

Mike spearheaded the integration of our two most recent acquisitions, Kremers Urban Pharmaceuticals and Silarx Pharmaceuticals, as well as a companywide restructuring and cost savings program, which we began implementing earlier this year, said Arthur Bedrosian chief executive officer of Lannett. With our path fo rward firmly developed and well underway, the integration continues to be on track and our experienced and talented team will assume control of and continue to execute our plan.

About Lannett Company, Inc.:

Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical

products for a wide range of medical indications. For more information, visit the companys website at

The above information was disclosed in a filing to the SEC. To see the filing, click here. Lannett Co Inc next reports earnings on May 04, 2016.

To receive a free e-mail notification whenever Lannett Co Inc makes a similar move, sign up!

Other recent filings from the company include the following: